It’s utterly simple. Stroke is a leading cause of death and long-term disability in the US, with heightened risk for low-income and marginalized groups. Outside of genetics, reducing these numbers ...

In 2023, the burden of stroke accounted for approximately 157 million disability-adjusted life years (DALYs), ranking second among all non-communicable diseases globally. Although age-standardised ...

The American Stroke Association just released new stroke prevention guidelines. They include considering GLP-1 receptor agonists. Doctors applaud the new guidance. More than 795,000 people in the U.S.

Each year in the U.S., over half a million people have a first stroke; however, up to 80% of strokes may be preventable. The new primary prevention of stroke guideline from the American Stroke ...

May is Stroke Awareness Month, and strokes continue to be a leading cause of disability and death, with nearly 800,000 strokes occurring annually in the U.S. alone. A large majority (80 percent) of ...

New guidelines from the AHA and ASA recommend GLP-1 drugs like Ozempic and Wegovy for stroke prevention in patients with diabetes and cardiovascular disease. They also highlight gender-specific risk ...

OpEd: Just small investments in lifesaving training and practices could lessen Kentucky deaths from heart attacks and strokes ...

Stroke is a life threatening medical emergency for which there are several modifiable risk factors. Individuals who want to reduce the likelihood of suffering a stroke may benefit from taking these ...

Erin Adelekun was 38 when she had a stroke, just nine days after giving birth to her daughter in 2020. It all started with a headache, which had been about a 2 on a scale of 1 to 10 when she was ...

Stroke prevention efforts are moving into the community, with the opening of the first condition-focused active ageing centre in Singapore. Run by Stroke Support Station (S3), it will provide more ...

The recently published results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial [1] showed that high-dose statin therapy could significantly reduce the risk of ...